» Articles » PMID: 35953459

MiR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS

Overview
Journal Shock
Date 2022 Aug 11
PMID 35953459
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia/reoxygenation (H/R) induces pyroptosis in the setting of acute myocardial infarction (AMI). Previous studies have shown that the expression of the miR-15 family is stimulated in myocardial ischemia-reperfusion injury or H/R-induced cardiomyocyte injury, and miR-15 is a promoter of cardiac ischemia-reperfusion or H/R injury. However, whether miR-15b-5p regulates H/R injury and cardiomyocyte pyroptosis and its mechanism still need to be further clarified. Bioinformatics analysis elicited that SIRT3 was the downstream regulatory target gene of miR-15b-5p. SIRT3 has been shown to participate in the regulation of pyroptosis by negatively regulating the NLRP3 inflammasome pathway. Therefore, we hypothesized that miR-15b-5p targets SIRT3 and activated the NLRP3 inflammasome pathway to promote H/R-induced cardiomyocyte pyroptosis. We first show that H/R increases miR-15b-5p in rat cardiomyocytes H9C2. Next, we tested the effects of inhibition of miR-15b-5p or overexpression of SIRT3. We found that miR-15b-5p downregulation or SIRT3 overexpression could reverse the H/R-induced pyroptosis. Furthermore, silencing SIRT3 antagonized the protective effect of miR-15b-5p downregulation on H9C2 cells. NLRP3 inhibitor MCC950 annulled the previously mentioned antagonistic effect of silencing SIRT3 on the protection of miR-15b-5p downregulation against pyroptosis. We then used a rat AMI model to analyze myocardial infarction area by triphenyl tetrazolium chloride staining and assess serum cardiac troponin T level by ELISA and found that miR-15b-5p silencing reduced AMI injury in rats. Collectively, these results suggest that miR-15b-5p increase H/R-induced pyroptosis in cardiomyocytes by targeting SIRT3 and activating the NLRP3 inflammasome.

Citing Articles

Programmed cardiomyocyte death in myocardial infarction.

Wu H, Lan Q, He Y, Xue J, Liu H, Zou Y Apoptosis. 2025; .

PMID: 39833636 DOI: 10.1007/s10495-025-02075-3.


MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells.

Kim J, Yu H, Kang J, Hong E, Kang M, Seong M J Ophthalmol. 2024; 2024:3654690.

PMID: 39220230 PMC: 11366061. DOI: 10.1155/2024/3654690.


MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4.

Martino E, DOnofrio N, Balestrieri A, Mele L, Sardu C, Marfella R Cell Mol Biol Lett. 2023; 28(1):66.

PMID: 37587410 PMC: 10428548. DOI: 10.1186/s11658-023-00482-5.


A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023.

Wang Y, Guo L, Zhang Z, Fu S, Huang P, Wang A Front Cardiovasc Med. 2023; 10:1180792.

PMID: 37383699 PMC: 10293770. DOI: 10.3389/fcvm.2023.1180792.


MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.

Kuang Z, Wu J, Tan Y, Zhu G, Li J, Wu M Biomolecules. 2023; 13(3).

PMID: 36979503 PMC: 10046787. DOI: 10.3390/biom13030568.